Organon Announces Proposed Senior Notes Offering
The Pharma Data
APRIL 6, 2021
Led by the growing reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health.
Let's personalize your content